Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LIMN

Liminatus Pharma, Inc.

CIK 0001971387 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$5.16
↑ 5.05 (4482.59%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$346.55M
P/E Ratio
-26.97
EPS
-0.43
Dividend Yield
Not covered
52W Position
88%
Beta
82.05

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1,152.80
P/S
Not covered
EV/Revenue
Not covered
ROE
-4274.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 88%
$0.10$5.88

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$10.21M
Total Assets
$512.79K
Free Cash Flow
-$9.98M

Recent news